1α,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo

Endocrinology

Volumn 151, Issue 1, 2010, Pages 23-31

  Gonzalez Pardo, Verónica ^a   Martin, Daniel ^b   Gutkind, J Silvio ^b   Verstuyf, Annemieke ^c   Bouillon, Roger ^c   De Boland, Ana Russo ^a   Boland, Ricardo L ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIS OIL; CALCITRIOL; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; G PROTEIN COUPLED RECEPTOR; PROTEIN P27; SHORT HAIRPIN RNA; TX 527; UNCLASSIFIED DRUG; VIRUS PROTEIN; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; ALKYNE; CALCITRIOL RECEPTOR; CHEMOKINE RECEPTOR; COLECALCIFEROL; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR, HUMAN HERPESVIRUS 8; G PROTEIN-COUPLED RECEPTOR, HUMAN HERPESVIRUS 8; TX 522; VITAMIN D;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; GENETIC TRANSFECTION; GENOME; GENOMICS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IN VITRO STUDY; IN VIVO STUDY; KAPOSI SARCOMA; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; TUMOR; TUMOR CELL; TUMOR GROWTH; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG SCREENING; FEMALE; GENETICS; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; VIRUS CELL TRANSFORMATION;

ALKYNES; ANIMALS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CHOLECALCIFEROL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, NUDE; MICE, SCID; RECEPTORS, CALCITRIOL; RECEPTORS, CHEMOKINE; VITAMIN D;

EID: 73649147052     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0650     Document Type: Article

References (30)

1. DeLuca H 2008 Evolution of our understanding of vitamin D. Nutr Rev 10:S73-S87
2. Beer TM, Myrthue A 2004 Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Ther 3:373-381
3. 3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41:231-240
4. Boland R, de Boland AR, Marinissen MJ, Santillan G, Vazquez G, Zanello S 1995 Avian muscle cells as targets for the secosteroid hormone 1,25-dihydroxy-vitamin D3. Mol Cell Endocrinol 114:1-8
5. 3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130. J Steroid Biochem Mol Biol 103:411-415
6. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M 2008 Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726-776
7. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS 2000 Kaposi sarcoma is a target for vitamin D3 receptor agonist. Blood 96:3188-3194
8. Memar OM, Rady PL, Tyring SK 1995 Human herpesvirus 8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions. J Mol Med 73:603-609
9. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS 1995 Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802
10. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS 2003 Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3:23-36
11. Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC, Lira SA 2006 The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 116:1264-1273
12. 3 stimulates intestinal cell p38 MAPK activity and increases c-fos expression. Int J Biochem Cell Biol 38:1181-1190
13. Bradford MM 1976 Arapid and sensitive method for quantification of micrograms quantities of proteins utilizing the principle of protein biding. Anal Biochem 72:248-254
14. Gocek E, Kielbiński M, Marchinkowska E 2007 Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett 581:1751-1757
15. Eelen G, Verlinden L, Van Camp M, Claessens F, De Clercq P, Vandewalle M, Bouillon R, Verstuyf A 2005 Altered vitamin D receptor-coactivator interactions reflect superagonism of vitaminD analogs. J Steroid Biochem Mol Biol 97:65-68
16. Chung I, Wong MK, Flynn G, YuWD, Johnson CS, Trump DL 2006 Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Res 66:8565-8573
17. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, Lira SA 2000 Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191:445-454
18. Guyton KZ, Kensler TW, Posner GH 2003 Vitamin D and vitamin Danalogs as cancer chemopreventive agents. Nutr Rev 61:227-238
19. Johnson CS, Hershberger PA, Bernardi RJ, McGuire TF, Trump DL 2002 Vitamin D receptor: a potential target for intervention. Urology 60:123-130; discussion 130-131
20. Eelen G, Gysemans C, Verlinden L, Vanoirbeek De Clercq EP, Van Haver D, Mathieu C, Bouillon R, Verstuyf A 2007 Mechanism and potential of the growth-inhibitory actions of vitaminDand analogs. Curr Med Chem 14:1893-1910
21. Bouillon R, Verlinden L, Eelen G, De Clercq P, Vandewalle M, Mathieu C, Verstuyf A 2005 Mechanisms for the selective actions of vitamin D analogs. J Steroid Biochem Mol Biol 97:21-30
22. Verlinden L, Verstuyf A, Van Camp M, Marcelis S, Sabbe K, Zhao XY, De Clerq P, Vandewalle M, Boullion R 2000 Two novel 14-epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 60:2673-2679
23. Deeb KK, Trump DL, Johnson CS 2007 Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684-700
24. 3, a natural metabolite of calcitriol. J Steroid Biochem Mol Biol 89-90:427-431
25. 3 inhibits angiogenesis in vitro and in vivo. Circ Res 87:214-220
26. 3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 81:730-733
27. Wang J, Lian H, Zhao Y, Kauss MA, Spindel S 2008 Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283:25596-25605
28. Wu W, Zhang X, Zanello LP 2007 1α,25-Dihydroxyvitamin D3 antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) up-regulation in human osteosarcoma. Cancer Lett 254:75-86
29. 1 by promoting cyclin D1 protein turnover. Cell Signal 20:1986-1994
30. Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS 2008 An NF-κB gene signature contributes to Kaposis's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27:1844-1852